ESR1 and cancer: Triple-negative breast cancer (TNBC) is an aggressive metastatic breast cancer (MBC) cancer characterized by the absence of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) [2].